ArticleMolecular therapy oncolytics2019

MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring

Hao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.